U13TR003935
Cooperative Agreement
Overview
Grant Description
Microphysiological Systems World Summit - Project Summary: Microphysiological Systems (MPS) comprise a number of bioengineering breakthroughs that reproduce organ architecture and function in vitro. Fueled by stem cell technologies, a broad variety of especially human models and test systems have emerged, which make relevant experimental tools broadly available through international and multi-disciplinary collaborations.
Conference(s) (series) are a key tool to form a community and accelerate scientific developments, their implementation, and global harmonization. They provide an overview of the state-of-the-art in such dynamic and diverse fields, enabling transfer learning. A global conference on MPS was identified by opinion leaders in the field as a key step forward in the maturation and harmonization of the area.
More than 30 international organizations and companies have teamed up for this proposal to initiate a series of annual MPS World Summits to present the latest scientific achievements, discuss the advances and challenges, and enable communication between young and newly interested scientists and pioneers of the MPS field. The conference should be a kick-off for an international MPS society. Bringing together the stakeholders from different areas (developers, life scientists, regulators, and regulated industry) will allow us to move these breakthrough technologies faster toward reliable, standardized, validated, and regulatory accepted tools in biomedical sciences.
The conferences are planned for New Orleans in May 2022 (hosts Don Ingber & Thomas Hartung), Europe late 2023 (likely in Berlin hosted by Uwe Marx & Marcel Leist), and on the US West Coast, late 2024, to reach out more to the Asia-Pacific region (hosted by Elaine Faustman & Thomas Neumann). Each conference will cover the broader aspects of MPS development and application to map the state of this technology and its challenges and opportunities.
Conference(s) (series) are a key tool to form a community and accelerate scientific developments, their implementation, and global harmonization. They provide an overview of the state-of-the-art in such dynamic and diverse fields, enabling transfer learning. A global conference on MPS was identified by opinion leaders in the field as a key step forward in the maturation and harmonization of the area.
More than 30 international organizations and companies have teamed up for this proposal to initiate a series of annual MPS World Summits to present the latest scientific achievements, discuss the advances and challenges, and enable communication between young and newly interested scientists and pioneers of the MPS field. The conference should be a kick-off for an international MPS society. Bringing together the stakeholders from different areas (developers, life scientists, regulators, and regulated industry) will allow us to move these breakthrough technologies faster toward reliable, standardized, validated, and regulatory accepted tools in biomedical sciences.
The conferences are planned for New Orleans in May 2022 (hosts Don Ingber & Thomas Hartung), Europe late 2023 (likely in Berlin hosted by Uwe Marx & Marcel Leist), and on the US West Coast, late 2024, to reach out more to the Asia-Pacific region (hosted by Elaine Faustman & Thomas Neumann). Each conference will cover the broader aspects of MPS development and application to map the state of this technology and its challenges and opportunities.
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Baltimore,
Maryland
21205
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 195% from $149,700 to $441,100.
The Johns Hopkins University was awarded
Microphysiological Systems World Summit
Cooperative Agreement U13TR003935
worth $441,100
from National Center for Advancing Translational Sciences in September 2021 with work to be completed primarily in Baltimore Maryland United States.
The grant
has a duration of 2 years 10 months and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 8/21/23
Period of Performance
9/15/21
Start Date
7/31/24
End Date
Funding Split
$441.1K
Federal Obligation
$0.0
Non-Federal Obligation
$441.1K
Total Obligated
Activity Timeline
Transaction History
Modifications to U13TR003935
Additional Detail
Award ID FAIN
U13TR003935
SAI Number
U13TR003935-1623208523
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Funding Office
75NR00 NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Awardee UEI
FTMTDMBR29C7
Awardee CAGE
5L406
Performance District
MD-07
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $291,400 | 100% |
Modified: 8/21/23